Zolgensma

$50,000.00

Category:

Description

Zolgensma, a new drug approved by the FDA Friday, costs more than $2.1 million. It’s made by AveXis, a drugmaker owned by pharmaceutical giant Novartis. The federal Food and Drug Administration has approved a gene therapy for a rare childhood disorder that is now the most expensive drug on the market.

Reviews

There are no reviews yet.

Be the first to review “Zolgensma”

Your email address will not be published. Required fields are marked *

X
× +97152 238 1801